Stock Events

Stock Events

Avalo Therapeutics (C6K0.F) Q3 2024 Earnings

12AugConfirmed

Q2 2024

Q3 2024

-130.63

-87.45

-44.27

-1.09

Details

Expected EPS

-6.126614

Actual EPS

-12.8658894

Surprise EPS

-6.74

Surprise Percent

+110%

Description

Avalo Therapeutics (C6K0.F) has reported earnings of -12.8658894 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.